9 completed. 9 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 9 |
| Phase 2 | 2 | Completed 2 |
Follow Dilatation, Pathologic: new trials by email Literature Review of Dilatation, Pathologic trials Research Report on Dilatation, Pathologic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Pediatric Subjects Phentolamine Ophthalmic Solution 0.75%, Phentolamine Ophthalmic Solution Vehicle - Mydriasis, Dilation | Phase 3 | Completed | Opus Genetics, Inc | 23 | 2021-12-17 | 2026-10-30 |
| Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis (MIRA-3) Phentolamine Ophthalmic Solution 0.75%, Phentolamine Ophthalmic Solution Vehicle - Mydriasis, Dilation | Phase 3 | Completed | Opus Genetics, Inc | 368 | 2021-11-18 | 2026-10-30 |
| Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis Phentolamine Ophthalmic Solution 0.75%, Phentolamine Ophthalmic Solution Vehicle (Placebo) - Mydriasis, Dilation | Phase 3 | Completed | Opus Genetics, Inc | 185 | 2020-11-18 | 2026-10-30 |
| Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o 40cc buffered 0.5% lidocaine with 2 units of vasopressin paracervical block, 20cc 1% lidocaine with 2 units of vasopressin paracervical block - Abortion, Spontaneous, Abortion in First Trimester | Phase 3 | Completed | University of California, San Diego | 114 | 2018-10-29 | 2023-04-20 |
| Hysteroscopy After Pretreatment With Misoprostol and Estradiol Trial Misoprostol, Placebo - Cervical Ripening | Phase 3 | Completed | Ullevaal University Hospital | 100 | 2008-01-01 | 2009-05-25 |
| Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus and Corneal Ectasia Corneal collagen, Sham comparator - Progressive Keratoconus, Corneal Ectasia | Phase 2 / Phase 3 | Completed | Emory University | 160 | 2007-12-01 | 2010-09-02 |
| Corneal Collagen Cross-Linking for Ectasia (CXL) riboflavin ophthalmic solution, UVA Irradiation - Ectasia | Phase 3 | Completed | Glaukos Corporation | 130 | 2007-12-01 | 2021-04-26 |
| Hysteroscopy and Misoprostol Project misoprostol and cervical ripening - Uterine Hemorrhage | Phase 3 | Completed | Ullevaal University Hospital | 86 | 2006-09-01 | 2007-08-07 |
| A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures. AQUAVAN® (fospropofol disodium) Injection - Procedural Sedation | Phase 2 / Phase 3 | Completed | Eisai Inc. | 123 | 2006-05-01 | 2012-06-20 |
Mydriasis (3) · Corneal Diseases (2) · Abortion, Missed (1) · Abortion, Spontaneous (1) · Arteriovenous Fistula (1) · Bunion (1) · Keratoconus (1) · Uterine Hemorrhage (1)
Pathological Conditions, Anatomical (9) · Pathological Conditions, Signs and Symptoms (9) · Eye Diseases (5) · Pupil Disorders (3) · Female Urogenital Diseases and Pregnancy Complications (2) · Urogenital Diseases (2) · Arteriovenous Malformations (1) · Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Female Urogenital Diseases (1) · Fistula (1) · Foot Deformities (1) · Foot Deformities, Acquired (1)
Misoprostol (2) · Cervical Ripening (1) · Corneal Cross-Linking (1) · Injections (1) · Lidocaine (1) · fospropofol (1)
Opus Genetics, Inc (3) · Ullevaal University Hospital (2) · Eisai Inc. (1) · Emory University (1) · Glaukos Corporation (1) · University of California, San Diego (1)
United States (7) · Norway (2)
Britt-Ingjerd Nesheim, MD PhD (1) · Britt-Ingjerd Nesheim, MD, PhD (1) · Charles Slonim, MD (1) · James B Jones, MD, PharmD (1) · Peter Hersh, MD (1) · R. Doyle Stulting, MD, PhD (1) · Sheila K Mody, MD MPH (1)